Emergent BioSolutions Inc. — Director's Dealing 2021

Mar 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2021-03-04

Reporting Person: Bailey Sue (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-04	Common Stock	S	8168	$92.37	Disposed	24427	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2: These shares are held of record by a living trust, for which the Reporting Person serves as Trustee.

F3: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $91.01 to $93.50.